Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Issue 7 - Jul15

Denosumab — prescribe by brand; Flucloxacillin and hepatic disorders; SGLT2 inhibitors: risk of diabetic ketoacidosis; IV Medusa guide removed; New NICE guidance; Managed Entry decisions

File size: 478.09 KB
Created: 06/07/2015
Updated: 18/02/2019
Hits: 1561
Download